683 Capital Management’s TG Therapeutics TGTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-295,000	Closed	-$11.6M	–	143
2025 Q1	$11.6M	Sell	295,000 -402,000	-58%	-$15.9M	0.8%	25
2024 Q4	$21M	Sell	697,000 -438,000	-39%	-$13.2M	1.3%	13
2024 Q3	$26.5M	Sell	1,135,000 -265,000	-19%	-$6.2M	2.02%	8
2024 Q2	$24.9M	Sell	1,400,000 -225,000	-14%	-$4M	1.88%	9
2024 Q1	$24.7M	Sell	1,625,000 -50,000	-3%	-$761K	1.81%	11
2023 Q4	$28.6M	Buy	1,675,000 +325,000	+24%	+$5.55M	2.34%	8
2023 Q3	$11.3M	Buy	+1,350,000	New	+$11.3M	0.88%	32
2023 Q2	–	Sell	-775,000	Closed	-$11.7M	–	231
2023 Q1	$11.7M	Sell	775,000 -475,000	-38%	-$7.14M	0.87%	29
2022 Q4	$14.8M	Sell	1,250,000 -1,534,000	-55%	-$18.1M	1.25%	24
2022 Q3	$16.5M	Sell	2,784,000 -516,000	-16%	-$3.05M	1.27%	26
2022 Q2	$14M	Buy	3,300,000 +701,105	+27%	+$2.98M	0.99%	32
2022 Q1	$24.7M	Buy	2,598,895 +1,391,895	+115%	+$13.2M	1.32%	16
2021 Q4	$22.9M	Buy	1,207,000 +378,729	+46%	+$7.2M	0.84%	22
2021 Q3	$27.6M	Buy	828,271 +585,000	+240%	+$19.5M	1.08%	19
2021 Q2	$9.44M	Hold	243,271	–	–	0.33%	56
2021 Q1	$11.7M	Sell	243,271 -155,000	-39%	-$7.47M	0.62%	37
2020 Q4	$20.7M	Hold	398,271	–	–	0.98%	19
2020 Q3	$10.7M	Hold	398,271	–	–	0.78%	27
2020 Q2	$7.76M	Hold	398,271	–	–	0.62%	31
2020 Q1	$3.92M	Hold	398,271	–	–	0.46%	39
2019 Q4	$4.42M	Sell	398,271 -1,729	-0.4%	-$19.2K	0.51%	37
2019 Q3	$2.25M	Sell	400,000 -95,000	-19%	-$533K	0.25%	45
2019 Q2	$4.28M	Sell	495,000 -30,000	-6%	-$260K	0.39%	39
2019 Q1	$4.22M	Buy	525,000 +25,000	+5%	+$201K	0.38%	41
2018 Q4	$2.05M	Hold	500,000	–	–	0.12%	55
2018 Q3	$2.8M	Buy	+500,000	New	+$2.8M	0.18%	47